Karma is still around, with a design facility in Irvine, California, and an assembly plant in Moreno Valley, Calif. And cars ...

Nissan is one of the many automakers to have embraced the CVT over the past few years. But which of the automaker's many ...

A forgotten Le Mans prototype with a tiny engine and wild design reemerges decades later at Villa d’Este, still running ...

Two tiny turbocharged three-cylinder engines are offered in the Trailblazer. The standard 1.2-liter engine produces 137 hp and 162 lb-ft of torque. It's connected to a CVT automatic and is FWD only.

In the 30 model, a 2.0-liter four-cylinder engine adopts 48V mild hybrid tech to produce 255 hp and 295 lb-ft of torque. This is an improvement of 7 hp and 37 lb-ft over the previous four-cylinder.

plus or minus 5bp Tranche 2: Mid-swaps plus 40bp (final) Tranche 3: Mid-swaps plus 65bp (final) Tranche 4: Mid-swaps plus 80bp (final) Tranche 5: Mid-swaps plus 105bp (final) Denmark’s Novo ...

COLUMBUS, Ohio (WCMH) — Columbus City Council has approved $2.5 million for a new fire truck. This comes as the local firefighters’ union raised the alarm about a critical fire vehicle ...

Lexus RX and Volkswagen Touareg Kia has steadfastly defended its choice to stick with a 2.2-litre four-cylinder turbodiesel engine (154kW/440Nm) for the launch of its new Kia Tasman ute, despite ...

Novo Nordisk and Septerna have announced a new partnership worth $2.2bn to develop oral small molecule drugs for type 2 diabetes, obesity and other cardiometabolic diseases. The exclusive global ...

FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic ...

Pharmaceutical giant Novo Nordisk (NVO) inks a $2.2 billion deal with biotech company Septerna (SEPN) to develop a GLP-1 weight-loss drug in the form of an oral pill. Septerna's stock is skyrocketing ...

COPENHAGEN (Reuters) -Novo Nordisk (NVO) has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule medicines for obesity, type 2 diabetes and other ...